Keywords: new, study, validates, roche, xelox, colorectal, cancer

New study validates Roche's XELOX in colorectal cancer

Article | 07 August 2006

Swiss drug major Roche has reported positive data on a chemotherapy regimen containing its drug Xeloda (capecitabine). The large, international ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

capecitabine

Xeloda

Avastin

bevacizumab

Carac

Go to drug listing